FDA Label for Cystex Max Uti Pain Relief
View Indications, Usage & Precautions
Cystex Max Uti Pain Relief Product Label
The following document was submitted to the FDA by the labeler of this product Clarion Brands, Llc. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient
Phenazopyridine hydrochloride 99.5 mg
Purpose
Urinary tract analgesic
Indications & Usage
Use fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections. Treatment should not exceed 2 days without consulting a doctor; see Directions.
Warnings
- Do not exceed recommended dosage
- Long-term administration of phenazopyridine hydrochloride has induced neoplasia in rats (large intestine) and mice (liver). Although no association between phenazopyridine hydrochloride and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted.
Do Not Use
if you have Glucose-6-Phosphare Dehydrogenase (G6PD) deficiency unless approved by your doctor
Ask A Doctor Before Use If You Have
- kidney disease
- allergies to foods, preservatives or dyes
- had a hypersensitive reaction to phenazopyridine hydrochloride
When Using This Product
- do not exceed recommended dosage
- stomach upset may occur, taking this product with or after meals may reduce stomach upset
- your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.
- do not use for more than 2 days (12 tablets) without consulting a doctor
Stop Use And Ask A Doctor If
- your symptoms last for more than 2 days
- you suspect you are having an adverse reaction to the medication
Otc - Pregnancy Or Breast Feeding
If pregnant or breast-feeding, ask a health professional before use. A pregnancy test and consultation with a healthcare professional if pregnancy is confirmed is recommended prior to use
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
Adults and children 12 years of age and older: take 2 tablets 3 times a day with a full glass of water or after meals as needed
- children under 12 years:
- ask a doctor
Other Information
- WARNING: This product contains Phenazopyridine Hydrochloride, known to the state of California to cause cancer.
- this product can interfere with laboratory tests including urine, glucose (sugar), and ketones tests
- this product may stain soft contact lenses and other items if handled after touching tablets
- store at room temperature 59°F-86°F (15°C-30°C) in a dry place and protect from light
Tamper evident: Product is sealed within blisters. Do not use if any part of the blister is torn, open or damaged.
Inactive Ingredients
corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodium starch glycolate, talc, triacetin
Questions
call 1-844-297-8394
Principal Display Panel
MAX STRENGTH
Cystex®
Urinary Health
Phenazopyridine Hydrochloride 99.5 mg
MAX UTI PAIN RELIEF
FAST-ACTING UTI PAIN RELIEF
Strongest UTI Pain Relief Available
for Fast-Acting Relief of Pain & Burning*
√ Relief of Pain, Burning, & Urgency
√ Targets Pain at the Source of the UTI
STARTS
WORKING
IN AS LITTLE AS
15 MINUTES
Cystex is not intended to replace a doctor's care.
24 Tablets
TAMPER EVIDENT: TABLETS SEALED IN BLISTER. DO NOT USE IF BLISTER IS OPENED OR DAMAGED.
1000284
REV XX/XX REESECODE
For more information on
Cystex Max Strength UTI Pain
Relief or other products, please
visit www.cystex.com or call
844-297-8394
Distributed by: Cystex LLC
811 Broad Street, Suite 600
Chattanooga, TN 37402 ©2024
*without a prescription
* Please review the disclaimer below.